RadioMed Corporation develops radioactive stents for the treatment of coronary restenosis. The company was founded in 1997 and is based in Tyngsboro, Massachusetts. As of January 13, 2003, RadioMed Corporation operates as a subsidiary of Ion Beam Applications SA